- Home
- KWR vs CPRX Comparison
KWR vs CPRX Comparison
Compare KWR & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KWR
- CPRX
- Stock Information
- Founded
- KWR 1918
- CPRX 2002
- Country
- KWR United States
- CPRX United States
- Employees
- KWR N/A
- CPRX N/A
- Industry
- KWR Major Chemicals
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- KWR Industrials
- CPRX Health Care
- Exchange
- KWR Nasdaq
- CPRX Nasdaq
- Market Cap
- KWR 2.5B
- CPRX 2.6B
- IPO Year
- KWR 1985
- CPRX 2006
- Fundamental
- Price
- KWR $140.47
- CPRX $20.07
- Analyst Decision
- KWR Strong Buy
- CPRX Strong Buy
- Analyst Count
- KWR 5
- CPRX 5
- Target Price
- KWR $148.60
- CPRX $33.20
- AVG Volume (30 Days)
- KWR 133.8K
- CPRX 1.5M
- Earning Date
- KWR 10-30-2025
- CPRX 11-05-2025
- Dividend Yield
- KWR 1.45%
- CPRX N/A
- EPS Growth
- KWR N/A
- CPRX 183.96
- EPS
- KWR N/A
- CPRX 1.65
- Revenue
- KWR $1,832,674,000.00
- CPRX $558,499,000.00
- Revenue This Year
- KWR $2.14
- CPRX $16.51
- Revenue Next Year
- KWR $5.27
- CPRX $9.58
- P/E Ratio
- KWR N/A
- CPRX $12.13
- Revenue Growth
- KWR N/A
- CPRX 28.55
- 52 Week Low
- KWR $95.91
- CPRX $19.15
- 52 Week High
- KWR $180.97
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- KWR 54.44
- CPRX 46.94
- Support Level
- KWR $136.95
- CPRX $19.66
- Resistance Level
- KWR $142.33
- CPRX $20.52
- Average True Range (ATR)
- KWR 4.14
- CPRX 0.67
- MACD
- KWR -0.94
- CPRX 0.02
- Stochastic Oscillator
- KWR 57.41
- CPRX 44.55
About KWR Quaker Houghton
Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).